Homology Modeling of the Human P-glycoprotein (ABCB1) and Insights into Ligand Binding through Molecular Docking Studies
The ABCB1 transporter also known as P-glycoprotein (P-gp) is a transmembrane protein belonging to the ATP binding cassette super-family of transporters; it is a xenobiotic efflux pump that limits intracellular drug accumulation by pumping the compounds out of cells. P-gp contributes to a decrease of...
Gespeichert in:
Veröffentlicht in: | International journal of molecular sciences 2020-06, Vol.21 (11), p.4058 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | 11 |
container_start_page | 4058 |
container_title | International journal of molecular sciences |
container_volume | 21 |
creator | Mora Lagares, Liadys Minovski, Nikola Caballero Alfonso, Ana Yisel Benfenati, Emilio Wellens, Sara Culot, Maxime Gosselet, Fabien Novič, Marjana |
description | The ABCB1 transporter also known as P-glycoprotein (P-gp) is a transmembrane protein belonging to the ATP binding cassette super-family of transporters; it is a xenobiotic efflux pump that limits intracellular drug accumulation by pumping the compounds out of cells. P-gp contributes to a decrease of toxicity and possesses broad substrate specificity. It is involved in the failure of numerous anticancer and antiviral chemotherapies due to the multidrug resistance (MDR) phenomenon, where it removes the chemotherapeutics out of the targeted cells. Understanding the details of the ligand-P-gp interaction is therefore crucial for the development of drugs that might overcome the MRD phenomenon and for obtaining a more effective prediction of the toxicity of certain compounds. In this work, an in silico modeling was performed using homology modeling and molecular docking methods with the aim of better understanding the ligand-P-gp interactions. Based on different mouse P-gp structural templates from the PDB repository, a 3D model of the human P-gp (
P-gp) was constructed by means of protein homology modeling. The homology model was then used to perform molecular docking calculations on a set of thirteen compounds, including some well-known compounds that interact with P-gp as substrates, inhibitors, or both. The sum of ranking differences (SRD) was employed for the comparison of the different scoring functions used in the docking calculations. A consensus-ranking scheme was employed for the selection of the top-ranked pose for each docked ligand. The docking results showed that a high number of π interactions, mainly π-sigma, π-alkyl, and π-π type of interactions, together with the simultaneous presence of hydrogen bond interactions contribute to the stability of the ligand-protein complex in the binding site. It was also observed that some interacting residues in
P-gp are the same when compared to those observed in a co-crystallized ligand (PBDE-100) with mouse P-gp (PDB ID: 4XWK). Our in silico approach is consistent with available experimental results regarding P-gp efflux transport assay; therefore it could be useful in the prediction of the role of new compounds in systemic toxicity. |
doi_str_mv | 10.3390/ijms21114058 |
format | Article |
fullrecord | <record><control><sourceid>pubmed_hal_p</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7312539</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>32517082</sourcerecordid><originalsourceid>FETCH-LOGICAL-c418t-a18505ddeb5dbecac0c1c942bf142fb13b32fb76605368460a7b2ce911307a3c3</originalsourceid><addsrcrecordid>eNpdkctLw0AQxhdRrFZvnmWPFozuI8-L0NZHChEF9Rw2u5tka7Jbskmx_70J1VI9fcPMNz9m-AC4wOiG0gjdqmVtCcbYRV54AE6wS4iDkB8c7tUjcGrtEiFCiRcdg1EvOEAhOQFfsalNZYoNfDZCVkoX0OSwLSWMu5pp-OoU1YabVWNaqTS8ms7mMzyBTAu40FYVZWuh0q2BiSqG5kxpMUDasjFdUfbUSvKuYg28N_xzmLy1nVDSnoGjnFVWnv_oGHw8PrzPYyd5eVrMp4nDXRy2DsOhhzwhZOaJTHLGEcc8ckmW98_lGaYZ7SXwfeRRP3R9xIKMcBlhTFHAKKdjcLflrrqsloJL3TasSleNqlmzSQ1T6d-JVmVamHUaUEw8GvWAyRZQ_luLp0k69FBvDAgN17j3Xm-9vDHWNjLfLWCUDmml-2n19sv923bm33joNxN_kZA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Homology Modeling of the Human P-glycoprotein (ABCB1) and Insights into Ligand Binding through Molecular Docking Studies</title><source>MEDLINE</source><source>MDPI - Multidisciplinary Digital Publishing Institute</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Mora Lagares, Liadys ; Minovski, Nikola ; Caballero Alfonso, Ana Yisel ; Benfenati, Emilio ; Wellens, Sara ; Culot, Maxime ; Gosselet, Fabien ; Novič, Marjana</creator><creatorcontrib>Mora Lagares, Liadys ; Minovski, Nikola ; Caballero Alfonso, Ana Yisel ; Benfenati, Emilio ; Wellens, Sara ; Culot, Maxime ; Gosselet, Fabien ; Novič, Marjana</creatorcontrib><description>The ABCB1 transporter also known as P-glycoprotein (P-gp) is a transmembrane protein belonging to the ATP binding cassette super-family of transporters; it is a xenobiotic efflux pump that limits intracellular drug accumulation by pumping the compounds out of cells. P-gp contributes to a decrease of toxicity and possesses broad substrate specificity. It is involved in the failure of numerous anticancer and antiviral chemotherapies due to the multidrug resistance (MDR) phenomenon, where it removes the chemotherapeutics out of the targeted cells. Understanding the details of the ligand-P-gp interaction is therefore crucial for the development of drugs that might overcome the MRD phenomenon and for obtaining a more effective prediction of the toxicity of certain compounds. In this work, an in silico modeling was performed using homology modeling and molecular docking methods with the aim of better understanding the ligand-P-gp interactions. Based on different mouse P-gp structural templates from the PDB repository, a 3D model of the human P-gp (
P-gp) was constructed by means of protein homology modeling. The homology model was then used to perform molecular docking calculations on a set of thirteen compounds, including some well-known compounds that interact with P-gp as substrates, inhibitors, or both. The sum of ranking differences (SRD) was employed for the comparison of the different scoring functions used in the docking calculations. A consensus-ranking scheme was employed for the selection of the top-ranked pose for each docked ligand. The docking results showed that a high number of π interactions, mainly π-sigma, π-alkyl, and π-π type of interactions, together with the simultaneous presence of hydrogen bond interactions contribute to the stability of the ligand-protein complex in the binding site. It was also observed that some interacting residues in
P-gp are the same when compared to those observed in a co-crystallized ligand (PBDE-100) with mouse P-gp (PDB ID: 4XWK). Our in silico approach is consistent with available experimental results regarding P-gp efflux transport assay; therefore it could be useful in the prediction of the role of new compounds in systemic toxicity.</description><identifier>ISSN: 1422-0067</identifier><identifier>ISSN: 1661-6596</identifier><identifier>EISSN: 1422-0067</identifier><identifier>DOI: 10.3390/ijms21114058</identifier><identifier>PMID: 32517082</identifier><language>eng</language><publisher>Switzerland: MDPI</publisher><subject>Animals ; Antineoplastic Agents - chemistry ; Antineoplastic Agents - pharmacology ; ATP Binding Cassette Transporter, Subfamily B, Member 1 - chemistry ; ATP Binding Cassette Transporter, Subfamily B, Member 1 - metabolism ; Binding Sites ; Biochemistry, Molecular Biology ; Density Functional Theory ; Drug Discovery - methods ; Hydrogen Bonding ; Life Sciences ; Ligands ; Molecular Docking Simulation ; Molecular Dynamics Simulation ; Protein Binding ; Protein Conformation ; Reproducibility of Results ; Structural Biology ; Structure-Activity Relationship</subject><ispartof>International journal of molecular sciences, 2020-06, Vol.21 (11), p.4058</ispartof><rights>Attribution - NonCommercial</rights><rights>2020 by the authors. 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c418t-a18505ddeb5dbecac0c1c942bf142fb13b32fb76605368460a7b2ce911307a3c3</citedby><cites>FETCH-LOGICAL-c418t-a18505ddeb5dbecac0c1c942bf142fb13b32fb76605368460a7b2ce911307a3c3</cites><orcidid>0000-0002-0481-5026 ; 0000-0002-6205-4675 ; 0000-0003-0039-2246 ; 0000-0001-7452-0867</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7312539/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7312539/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27923,27924,53790,53792</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32517082$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://univ-artois.hal.science/hal-03127238$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Mora Lagares, Liadys</creatorcontrib><creatorcontrib>Minovski, Nikola</creatorcontrib><creatorcontrib>Caballero Alfonso, Ana Yisel</creatorcontrib><creatorcontrib>Benfenati, Emilio</creatorcontrib><creatorcontrib>Wellens, Sara</creatorcontrib><creatorcontrib>Culot, Maxime</creatorcontrib><creatorcontrib>Gosselet, Fabien</creatorcontrib><creatorcontrib>Novič, Marjana</creatorcontrib><title>Homology Modeling of the Human P-glycoprotein (ABCB1) and Insights into Ligand Binding through Molecular Docking Studies</title><title>International journal of molecular sciences</title><addtitle>Int J Mol Sci</addtitle><description>The ABCB1 transporter also known as P-glycoprotein (P-gp) is a transmembrane protein belonging to the ATP binding cassette super-family of transporters; it is a xenobiotic efflux pump that limits intracellular drug accumulation by pumping the compounds out of cells. P-gp contributes to a decrease of toxicity and possesses broad substrate specificity. It is involved in the failure of numerous anticancer and antiviral chemotherapies due to the multidrug resistance (MDR) phenomenon, where it removes the chemotherapeutics out of the targeted cells. Understanding the details of the ligand-P-gp interaction is therefore crucial for the development of drugs that might overcome the MRD phenomenon and for obtaining a more effective prediction of the toxicity of certain compounds. In this work, an in silico modeling was performed using homology modeling and molecular docking methods with the aim of better understanding the ligand-P-gp interactions. Based on different mouse P-gp structural templates from the PDB repository, a 3D model of the human P-gp (
P-gp) was constructed by means of protein homology modeling. The homology model was then used to perform molecular docking calculations on a set of thirteen compounds, including some well-known compounds that interact with P-gp as substrates, inhibitors, or both. The sum of ranking differences (SRD) was employed for the comparison of the different scoring functions used in the docking calculations. A consensus-ranking scheme was employed for the selection of the top-ranked pose for each docked ligand. The docking results showed that a high number of π interactions, mainly π-sigma, π-alkyl, and π-π type of interactions, together with the simultaneous presence of hydrogen bond interactions contribute to the stability of the ligand-protein complex in the binding site. It was also observed that some interacting residues in
P-gp are the same when compared to those observed in a co-crystallized ligand (PBDE-100) with mouse P-gp (PDB ID: 4XWK). Our in silico approach is consistent with available experimental results regarding P-gp efflux transport assay; therefore it could be useful in the prediction of the role of new compounds in systemic toxicity.</description><subject>Animals</subject><subject>Antineoplastic Agents - chemistry</subject><subject>Antineoplastic Agents - pharmacology</subject><subject>ATP Binding Cassette Transporter, Subfamily B, Member 1 - chemistry</subject><subject>ATP Binding Cassette Transporter, Subfamily B, Member 1 - metabolism</subject><subject>Binding Sites</subject><subject>Biochemistry, Molecular Biology</subject><subject>Density Functional Theory</subject><subject>Drug Discovery - methods</subject><subject>Hydrogen Bonding</subject><subject>Life Sciences</subject><subject>Ligands</subject><subject>Molecular Docking Simulation</subject><subject>Molecular Dynamics Simulation</subject><subject>Protein Binding</subject><subject>Protein Conformation</subject><subject>Reproducibility of Results</subject><subject>Structural Biology</subject><subject>Structure-Activity Relationship</subject><issn>1422-0067</issn><issn>1661-6596</issn><issn>1422-0067</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkctLw0AQxhdRrFZvnmWPFozuI8-L0NZHChEF9Rw2u5tka7Jbskmx_70J1VI9fcPMNz9m-AC4wOiG0gjdqmVtCcbYRV54AE6wS4iDkB8c7tUjcGrtEiFCiRcdg1EvOEAhOQFfsalNZYoNfDZCVkoX0OSwLSWMu5pp-OoU1YabVWNaqTS8ms7mMzyBTAu40FYVZWuh0q2BiSqG5kxpMUDasjFdUfbUSvKuYg28N_xzmLy1nVDSnoGjnFVWnv_oGHw8PrzPYyd5eVrMp4nDXRy2DsOhhzwhZOaJTHLGEcc8ckmW98_lGaYZ7SXwfeRRP3R9xIKMcBlhTFHAKKdjcLflrrqsloJL3TasSleNqlmzSQ1T6d-JVmVamHUaUEw8GvWAyRZQ_luLp0k69FBvDAgN17j3Xm-9vDHWNjLfLWCUDmml-2n19sv923bm33joNxN_kZA</recordid><startdate>20200605</startdate><enddate>20200605</enddate><creator>Mora Lagares, Liadys</creator><creator>Minovski, Nikola</creator><creator>Caballero Alfonso, Ana Yisel</creator><creator>Benfenati, Emilio</creator><creator>Wellens, Sara</creator><creator>Culot, Maxime</creator><creator>Gosselet, Fabien</creator><creator>Novič, Marjana</creator><general>MDPI</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>1XC</scope><scope>VOOES</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-0481-5026</orcidid><orcidid>https://orcid.org/0000-0002-6205-4675</orcidid><orcidid>https://orcid.org/0000-0003-0039-2246</orcidid><orcidid>https://orcid.org/0000-0001-7452-0867</orcidid></search><sort><creationdate>20200605</creationdate><title>Homology Modeling of the Human P-glycoprotein (ABCB1) and Insights into Ligand Binding through Molecular Docking Studies</title><author>Mora Lagares, Liadys ; Minovski, Nikola ; Caballero Alfonso, Ana Yisel ; Benfenati, Emilio ; Wellens, Sara ; Culot, Maxime ; Gosselet, Fabien ; Novič, Marjana</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c418t-a18505ddeb5dbecac0c1c942bf142fb13b32fb76605368460a7b2ce911307a3c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Animals</topic><topic>Antineoplastic Agents - chemistry</topic><topic>Antineoplastic Agents - pharmacology</topic><topic>ATP Binding Cassette Transporter, Subfamily B, Member 1 - chemistry</topic><topic>ATP Binding Cassette Transporter, Subfamily B, Member 1 - metabolism</topic><topic>Binding Sites</topic><topic>Biochemistry, Molecular Biology</topic><topic>Density Functional Theory</topic><topic>Drug Discovery - methods</topic><topic>Hydrogen Bonding</topic><topic>Life Sciences</topic><topic>Ligands</topic><topic>Molecular Docking Simulation</topic><topic>Molecular Dynamics Simulation</topic><topic>Protein Binding</topic><topic>Protein Conformation</topic><topic>Reproducibility of Results</topic><topic>Structural Biology</topic><topic>Structure-Activity Relationship</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mora Lagares, Liadys</creatorcontrib><creatorcontrib>Minovski, Nikola</creatorcontrib><creatorcontrib>Caballero Alfonso, Ana Yisel</creatorcontrib><creatorcontrib>Benfenati, Emilio</creatorcontrib><creatorcontrib>Wellens, Sara</creatorcontrib><creatorcontrib>Culot, Maxime</creatorcontrib><creatorcontrib>Gosselet, Fabien</creatorcontrib><creatorcontrib>Novič, Marjana</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Hyper Article en Ligne (HAL)</collection><collection>Hyper Article en Ligne (HAL) (Open Access)</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>International journal of molecular sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mora Lagares, Liadys</au><au>Minovski, Nikola</au><au>Caballero Alfonso, Ana Yisel</au><au>Benfenati, Emilio</au><au>Wellens, Sara</au><au>Culot, Maxime</au><au>Gosselet, Fabien</au><au>Novič, Marjana</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Homology Modeling of the Human P-glycoprotein (ABCB1) and Insights into Ligand Binding through Molecular Docking Studies</atitle><jtitle>International journal of molecular sciences</jtitle><addtitle>Int J Mol Sci</addtitle><date>2020-06-05</date><risdate>2020</risdate><volume>21</volume><issue>11</issue><spage>4058</spage><pages>4058-</pages><issn>1422-0067</issn><issn>1661-6596</issn><eissn>1422-0067</eissn><abstract>The ABCB1 transporter also known as P-glycoprotein (P-gp) is a transmembrane protein belonging to the ATP binding cassette super-family of transporters; it is a xenobiotic efflux pump that limits intracellular drug accumulation by pumping the compounds out of cells. P-gp contributes to a decrease of toxicity and possesses broad substrate specificity. It is involved in the failure of numerous anticancer and antiviral chemotherapies due to the multidrug resistance (MDR) phenomenon, where it removes the chemotherapeutics out of the targeted cells. Understanding the details of the ligand-P-gp interaction is therefore crucial for the development of drugs that might overcome the MRD phenomenon and for obtaining a more effective prediction of the toxicity of certain compounds. In this work, an in silico modeling was performed using homology modeling and molecular docking methods with the aim of better understanding the ligand-P-gp interactions. Based on different mouse P-gp structural templates from the PDB repository, a 3D model of the human P-gp (
P-gp) was constructed by means of protein homology modeling. The homology model was then used to perform molecular docking calculations on a set of thirteen compounds, including some well-known compounds that interact with P-gp as substrates, inhibitors, or both. The sum of ranking differences (SRD) was employed for the comparison of the different scoring functions used in the docking calculations. A consensus-ranking scheme was employed for the selection of the top-ranked pose for each docked ligand. The docking results showed that a high number of π interactions, mainly π-sigma, π-alkyl, and π-π type of interactions, together with the simultaneous presence of hydrogen bond interactions contribute to the stability of the ligand-protein complex in the binding site. It was also observed that some interacting residues in
P-gp are the same when compared to those observed in a co-crystallized ligand (PBDE-100) with mouse P-gp (PDB ID: 4XWK). Our in silico approach is consistent with available experimental results regarding P-gp efflux transport assay; therefore it could be useful in the prediction of the role of new compounds in systemic toxicity.</abstract><cop>Switzerland</cop><pub>MDPI</pub><pmid>32517082</pmid><doi>10.3390/ijms21114058</doi><orcidid>https://orcid.org/0000-0002-0481-5026</orcidid><orcidid>https://orcid.org/0000-0002-6205-4675</orcidid><orcidid>https://orcid.org/0000-0003-0039-2246</orcidid><orcidid>https://orcid.org/0000-0001-7452-0867</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1422-0067 |
ispartof | International journal of molecular sciences, 2020-06, Vol.21 (11), p.4058 |
issn | 1422-0067 1661-6596 1422-0067 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7312539 |
source | MEDLINE; MDPI - Multidisciplinary Digital Publishing Institute; EZB-FREE-00999 freely available EZB journals; PubMed Central |
subjects | Animals Antineoplastic Agents - chemistry Antineoplastic Agents - pharmacology ATP Binding Cassette Transporter, Subfamily B, Member 1 - chemistry ATP Binding Cassette Transporter, Subfamily B, Member 1 - metabolism Binding Sites Biochemistry, Molecular Biology Density Functional Theory Drug Discovery - methods Hydrogen Bonding Life Sciences Ligands Molecular Docking Simulation Molecular Dynamics Simulation Protein Binding Protein Conformation Reproducibility of Results Structural Biology Structure-Activity Relationship |
title | Homology Modeling of the Human P-glycoprotein (ABCB1) and Insights into Ligand Binding through Molecular Docking Studies |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T00%3A48%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_hal_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Homology%20Modeling%20of%20the%20Human%20P-glycoprotein%20(ABCB1)%20and%20Insights%20into%20Ligand%20Binding%20through%20Molecular%20Docking%20Studies&rft.jtitle=International%20journal%20of%20molecular%20sciences&rft.au=Mora%20Lagares,%20Liadys&rft.date=2020-06-05&rft.volume=21&rft.issue=11&rft.spage=4058&rft.pages=4058-&rft.issn=1422-0067&rft.eissn=1422-0067&rft_id=info:doi/10.3390/ijms21114058&rft_dat=%3Cpubmed_hal_p%3E32517082%3C/pubmed_hal_p%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/32517082&rfr_iscdi=true |